aromatase inhibitors ovulation induction, letrozole ovulation induction breast cancer, fertility preservation breast cancer survivors, aromatase inhibitors fertility treatment, ovulation induction cancer survivors, letrozole versus clomiphene breast cancer, fertility after breast cancer treatment, aromatase inhibitors infertility, breast cancer survivor fertility options, oncofertility ovulation induction, letrozole ovulation induction safety, fertility treatment breast cancer patients
Cite this article
Mitwally, M. F., & Casper, R. F. (2004). *Using Aromatase Inhibitors to Induce Ovulation in Breast CA Survivors*.
Mitwally MF, Casper RF. Using Aromatase Inhibitors to Induce Ovulation in Breast CA Survivors. 2004.
Mitwally, M. F., and R. F. Casper. *Using Aromatase Inhibitors to Induce Ovulation in Breast CA Survivors*. 2004.
The third-generation aromatase inhibitors were initially introduced to treat postmenopausal breast cancer. We now realize that many other potential indications for aromatase inhibitors exist, especial...
The use of platelet-rich plasma (PRP) has become popular as an adjunct to fertility treatment for women with infertility, particularly those with low ovarian reserve and premature ovarian insufficienc...
Background: Ovarian rejuvenation is an innovative procedure intended to restore ovarian fertility and development during the climacteric and has been used to enhance fertility in women with premature ...
RESEARCH Question: Is sequential letrozole/human menopausal gonadotrophin (HMG) superior to letrozole alone in ovulation induction and pregnancy promotion among infertile women with polycystic ovary s...